Phase 2 study of KET-IR
Latest Information Update: 14 Dec 2023
At a glance
- Drugs Ketamine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
Most Recent Events
- 14 Dec 2023 New trial record
- 24 Oct 2023 According to Neurocentrx Pharma media release, In the first half of 2024, Neurocentrx plans to initiate this study.